Eagle Bay Advisors LLC Gsk PLC Transaction History

Eagle Bay Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 22, 2022	SELL	$16.13 - $44.61 $1,790 - $4,951	-111 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$42.05 - $47.77 $4,667 - $5,302	111 New	111 $4.83 Million
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $9,293 - $11,027	-231 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$38.88 - $45.31 $8,981 - $10,466	-231 Reduced 50.0%	231 $10,000
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $10,162 - $11,307	262 Added 131.0%	462 $18,000
Q2 2021 Jul 30, 2021	BUY	$36.52 - $41.46 $7,304 - $8,292	200 New	200 $8,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Bay Advisors LLC with notifications on news.